Last Updated:
Unlisted shares ofDr Agarwalâs Health Care Ltd are trading at Rs 402.5 each in the grey market, which is simply 0.12 percent GMP over the top IPO cost of 402, suggesting level or adverse listing.
Dr Agarwals Healthcare IPO Allotment Status.
Dr Agarwals Healthcare IPO Allotment Status: Even as the Dr Agarwals Healthcare IPO has actually obtained a frustrating 1.49 times membership from financiers, the part is readied to be settled today, February 3, at night. Once set aside, financiers will certainly begin obtaining financial institution debit messages. They can likewise examine the part condition on the sites of the BSE and NSE, in addition to on registrar Kfin Technologies Ltd.
According to market viewers, the GMP is extremely reduced at 0.12 percent, recommending a level or adverse listing.
After the part is settled, the IPO listing is arranged to occur on February 5 on both BSE and NSE.
Dr Agarwals Healthcare IPO: How To Check Allotment Status Online?
The Dr Agarwals Healthcare IPO part will certainly occur on Monday, February 3, at night. The IPO part condition can be inspected on-line by complying with these actions:
1) Go to the main BSE site through the linkâ https://www.bseindia.com/investors/appli_check.aspx.
2) Under âIssue Typeâ, choose âEquityâ.
3) Under âIssue Nameâ, choose âDr. Agarwalâ s Health Care Ltdâ in the dropbox.
4) Enter your application number, or the Permanent Account Number (FRYING PAN).
5) Then, click the âI am not a robotâ to validate on your own and strike the âSearchâ alternative.
Your share application condition will certainly show up on your display.
You can likewise go to straight on the registrar Kfin Technologies Ltdâs websiteâ and examine the Dr Agarwals Healthcare IPO part condition.
Dr Agarwals Healthcare IPO GMP Today
According to market viewers, non listed shares ofDr Agarwalâs Health Care Ltd are presently trading at Rs 402.5 each in the grey market, which is a 0.12 percent costs over the top IPO cost of Rs 402. It shows a solid listing gain for financiers on February 5.
The GMP is based upon market views and maintains altering. âGrey market premiumâ shows financiersâ preparedness to pay greater than the concern cost.
Dr Agarwals Healthcare IPO: More Details
The preliminary public deal of Dr Agarwalâs Health Care Ltd, which was open for public membership in between January 29 and January 31, was subscribed 1.55 times on the closing day of bidding process. The Rs 3,027.26-crore public concern obtained quotes for 8,29,80,520 shares versus 5,35,26,172 shares available, according to the NSE information.
The part for Qualified Institutional Buyers (QIBs) obtained subscribed 4.64 times while the group for Retail Individual Investors (RIIs) obtained 41 percent membership. The allocation for non-institutional financiers obtained subscribed 39 percent.
Ahead of the IPO, Dr Agarwalâs Health Care increased over Rs 875.5 crore from support financiers.
The public concern has a rate band of Rs 382-402 per share.
The IPO is a mix of a fresh concern of as much as Rs 300 crore and an Offer For Sale (OFS) of as much as 6.78 crore equity shares worth Rs 2,727.26 crore by marketers and various other offering investors at the top end of the cost band.
Proceeds from the fresh concern to the song of Rs 195 crore will certainly be made use of for repayment of financial obligation. Besides, a section will certainly be made use of for basic business functions and unknown not natural procurements.
Overview About Dr Agarwalâs Health Care
Dr Agarwalâs Health Care uses a broad variety of solutions, consisting of cataract, refractive, and various other surgical procedures, appointments, medical diagnosis, non-surgical therapies, and the sale of optical items, get in touch with lenses, devices, and eye care-related pharmaceutical things.
As of September 2024, its network included 193 centers with a bulk focus in South India, specifically Chennai, Hyderabad and Bengaluru, complied with by Western India.
Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India and Motilal Oswal Investment Advisors are the book-running lead supervisors to the concern.
